Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.75%
#4 Black Phoenix Black Phoenix +334.12%
#5 aPriori aPriori +117.60%
#6 Bedrock Bedrock +71.13%
#7 Cysic Cysic +42.73%
#8 Prom Prom +38.17%
#9 COTI COTI +34.60%
#10 Playnance Playnance +34.46%
Coin of the day
Wrapped One Wrapped One
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Kedudukan dalam Saham #40
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Harga Saham
$481.73
Modal Pasaran
$377.65B
Perubahan (1 hari)
-0.96%
Perubahan (1 tahun)
50.07%
Negara
CH
Perdagangan Roche Holding AG (RO)

Kategori

Healthcare
Pendapatan untuk Roche Holding AG (RO)
Pendapatan pada Dec 2025 TTM: $21.39B
Menurut laporan kewangan terkini Roche Holding AG, pendapatan semasa syarikat ialah $21.39B. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Roche Holding AG dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B 57.07%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B 17.80%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -59.33%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -72.19%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
$16.38B -23.42%
CH